Literature DB >> 22473297

The pro-metastatic role of bone marrow-derived cells: a focus on MSCs and regulatory T cells.

Bong Ihn Koh1, Yibin Kang.   

Abstract

Several bone marrow-derived cells have been shown to promote tumour growth and progression. These cells can home to the primary tumour and become active components of the tumour microenvironment. Recent studies have also identified bone marrow-derived cells—such as mesenchymal stem cells and regulatory T cells—as contributors to cancer metastasis. The innate versatility of these cells provides diverse functional aid to promote malignancy, ranging from structural support to signal-mediated suppression of the host immune response. Here, we review the role of mesenchymal stem cells and regulatory T cells in cancer metastasis. A better understanding of the bipolar nature of these bone marrow-derived cells in physiological and malignant contexts could pave the way for new therapeutics against metastatic disease.

Entities:  

Mesh:

Year:  2012        PMID: 22473297      PMCID: PMC3343352          DOI: 10.1038/embor.2012.41

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  204 in total

Review 1.  Tumor metastasis: molecular insights and evolving paradigms.

Authors:  Scott Valastyan; Robert A Weinberg
Journal:  Cell       Date:  2011-10-14       Impact factor: 41.582

Review 2.  The origins of mesenchymal stromal cell heterogeneity.

Authors:  Meirav Pevsner-Fischer; Sarit Levin; Dov Zipori
Journal:  Stem Cell Rev Rep       Date:  2011-09       Impact factor: 5.739

3.  Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs.

Authors:  Thordur Oskarsson; Swarnali Acharyya; Xiang H-F Zhang; Sakari Vanharanta; Sohail F Tavazoie; Patrick G Morris; Robert J Downey; Katia Manova-Todorova; Edi Brogi; Joan Massagué
Journal:  Nat Med       Date:  2011-06-26       Impact factor: 53.440

4.  Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4⁺ T cells to T-regulatory cells.

Authors:  Purevdorj B Olkhanud; Bazarragchaa Damdinsuren; Monica Bodogai; Ronald E Gress; Ranjan Sen; Katarzyna Wejksza; Enkhzol Malchinkhuu; Robert P Wersto; Arya Biragyn
Journal:  Cancer Res       Date:  2011-03-28       Impact factor: 12.701

Review 5.  Mast cell: insight into remodeling a tumor microenvironment.

Authors:  Jing Liu; Yi Zhang; Jie Zhao; Zhuoshun Yang; Dapeng Li; Foad Katirai; Bo Huang
Journal:  Cancer Metastasis Rev       Date:  2011-06       Impact factor: 9.264

6.  CD8⁺ cytotoxic T cell and FOXP3⁺ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes.

Authors:  Fangfang Liu; Ronggang Lang; Jing Zhao; Xinmin Zhang; Gordon A Pringle; Yu Fan; Dong Yin; Feng Gu; Zhi Yao; Li Fu
Journal:  Breast Cancer Res Treat       Date:  2011-06-30       Impact factor: 4.872

7.  Interactions between cancer stem cells and their niche govern metastatic colonization.

Authors:  Ilaria Malanchi; Albert Santamaria-Martínez; Evelyn Susanto; Hong Peng; Hans-Anton Lehr; Jean-Francois Delaloye; Joerg Huelsken
Journal:  Nature       Date:  2011-12-07       Impact factor: 49.962

8.  CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis.

Authors:  Bin-Zhi Qian; Jiufeng Li; Hui Zhang; Takanori Kitamura; Jinghang Zhang; Liam R Campion; Elizabeth A Kaiser; Linda A Snyder; Jeffrey W Pollard
Journal:  Nature       Date:  2011-06-08       Impact factor: 49.962

9.  Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis.

Authors:  Myriam Labelle; Shahinoor Begum; Richard O Hynes
Journal:  Cancer Cell       Date:  2011-11-15       Impact factor: 31.743

10.  In situ prior proliferation of CD4+ CCR6+ regulatory T cells facilitated by TGF-β secreting DCs is crucial for their enrichment and suppression in tumor immunity.

Authors:  Lin Xu; Wei Xu; Zhenke Wen; Sidong Xiong
Journal:  PLoS One       Date:  2011-05-31       Impact factor: 3.240

View more
  20 in total

Review 1.  Tumour-associated mesenchymal stem/stromal cells: emerging therapeutic targets.

Authors:  Yufang Shi; Liming Du; Liangyu Lin; Ying Wang
Journal:  Nat Rev Drug Discov       Date:  2016-11-04       Impact factor: 84.694

Review 2.  De novo formed satellite DNA-based mammalian artificial chromosomes and their possible applications.

Authors:  Robert L Katona
Journal:  Chromosome Res       Date:  2015-02       Impact factor: 5.239

Review 3.  Human Mesenchymal Stem/Stromal Cells in Immune Regulation and Therapy.

Authors:  Éva Mezey
Journal:  Stem Cells Transl Med       Date:  2022-03-17       Impact factor: 6.940

Review 4.  Targeting tumor-stromal interactions in bone metastasis.

Authors:  Mark Esposito; Yibin Kang
Journal:  Pharmacol Ther       Date:  2013-10-15       Impact factor: 12.310

5.  Intraosseous inoculation of tumor cells into bone marrow promotes distant metastatic tumor development: A novel tool for mechanistic and therapeutic studies.

Authors:  Jeffry Cutrera; Blake Johnson; Lee Ellis; Shulin Li
Journal:  Cancer Lett       Date:  2012-10-27       Impact factor: 8.679

Review 6.  The metastasis-promoting roles of tumor-associated immune cells.

Authors:  Heath A Smith; Yibin Kang
Journal:  J Mol Med (Berl)       Date:  2013-03-21       Impact factor: 4.599

Review 7.  Concise Review: Pancreatic Cancer and Bone Marrow-Derived Stem Cells.

Authors:  Wojciech Błogowski; Tomasz Bodnarczuk; Teresa Starzyńska
Journal:  Stem Cells Transl Med       Date:  2016-05-23       Impact factor: 6.940

8.  Human bone marrow mesenchymal stem cells induce collagen production and tongue cancer invasion.

Authors:  Sirpa Salo; Carolina Bitu; Kalle Merkku; Pia Nyberg; Ibrahim O Bello; Jussi Vuoristo; Meeri Sutinen; Hannu Vähänikkilä; Daniela E Costea; Joonas H Kauppila; Joonas Kauppila; Petri Lehenkari; Dan Dayan; Marilena Vered; Juha Risteli; Tuula Salo
Journal:  PLoS One       Date:  2013-10-21       Impact factor: 3.240

Review 9.  Mesenchymal Stem Cells Engineered by Nonviral Vectors: A Powerful Tool in Cancer Gene Therapy.

Authors:  Yuan Ding; Chenyang Wang; Zhongquan Sun; Yingsheng Wu; Wanlu You; Zhengwei Mao; Weilin Wang
Journal:  Pharmaceutics       Date:  2021-06-21       Impact factor: 6.321

10.  EMT and acquisition of stem cell-like properties are involved in spontaneous formation of tumorigenic hybrids between lung cancer and bone marrow-derived mesenchymal stem cells.

Authors:  Mei-Hua Xu; Xuan Gao; Dan Luo; Xiang-Dong Zhou; Wei Xiong; Guo-Xiang Liu
Journal:  PLoS One       Date:  2014-02-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.